Ampersand Capital Partners portfolio company Avista Pharma Solutions (APS) has acquired Solid Form Solutions Limited (SFS).
The target company will operate from Edinburgh, Scotland, following the acquisition.
Go deeper with GlobalData
The acquisition will strengthen APS’s solid phase chemistry services.
Based in the UK, APS is a contract development and manufacturing organisation, while SFS is also based in the UK and involved in providing solid-state chemistry and crystallisation development services.
Venn Life Sciences Holdings Plc has increased its stake in Venn Life Sciences (France) SAS (VLSF) to 100% by acquiring the remaining 11.03% stake in the target company from Christian Le Bras (CLB).
CLB will continue to operate as head of interactive response technology in VLS, following the acquisition.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataThe acquisition will help Venn Life Sciences Holdings to reinforce its data management and clinical capabilities.
Both companies are clinical research organisations based in France.
